果聚糖而非麸质在自我报告非乳糜泻麸质敏感者中诱发症状
在挪威奥斯陆大学医院开展的双盲交叉激发试验中,59例自我报告非乳糜泻麸质敏感且已排除乳糜泻的受试者随机接受含麸质5.7 g、果聚糖2.1 g或安慰剂的饮食各7天。果聚糖组总体GSRS-IBS评分和腹胀评分显著高于麸质组,麸质与安慰剂组间无差异。
要点
- 果聚糖组总体GSRS-IBS评分显著高于麸质组(P=.049)。
- 果聚糖组GSRS-IBS腹胀评分显著高于麸质组(P=.003)。
- 麸质与安慰剂组间GSRS-IBS评分无差异。
核心结论
- 在自我报告非乳糜泻麸质敏感的受试者中,果聚糖而非麸质诱发以GSRS-IBS评估的症状。
研究设计与样本
- 随机双盲安慰剂对照交叉激发试验,纳入59例自我报告麸质敏感且已排除乳糜泻、自行采用无麸质饮食的个体。
- 研究于2014年10月至2016年5月在挪威奥斯陆大学医院进行。
- 受试者随机接受含麸质5.7 g、果聚糖2.1 g或安慰剂的饮食各7天, concealed in muesli bars,洗脱期至少7天。
主要发现
- 总体GSRS-IBS评分在麸质、果聚糖和安慰剂激发期间分别为33.1±13.3、38.6±12.3和34.3±13.9(P=.04)。
- GSRS-IBS腹胀评分在麸质、果聚糖和安慰剂激发期间分别为9.3±3.5、11.6±3.5和10.1±3.7(P=.004)。
- 果聚糖组总体GSRS-IBS评分显著高于麸质组(P=.049),腹胀评分亦显著高于麸质组(P=.003)。
- 麸质组与安慰剂组GSRS-IBS评分无差异。
- 13例受试者在摄入麸质后总体GSRS-IBS评分最高,24例在摄入果聚糖后最高,22例在摄入安慰剂后最高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Non-celiac gluten sensitivity is characterized by symptom improvement after gluten withdrawal in absence of celiac disease. The mechanisms of non-celiac gluten sensitivity are unclear, and there are no biomarkers for this disorder. Foods with gluten often contain fructans, a type of fermentable oligo-, di-, monosaccharides and polyols. We aimed to investigate the effect of gluten and fructans separately in individuals with self-reported gluten sensitivity. METHODS: We performed a double-blind crossover challenge of 59 individuals on a self-instituted gluten-free diet, for whom celiac disease had been excluded. The study was performed at Oslo University Hospital in Norway from October 2014 through May 2016. Participants were randomly assigned to groups placed on diets containing gluten (5.7 g), fructans (2.1 g), or placebo, concealed in muesli bars, for 7 days. Following a minimum 7-day washout period (until the symptoms induced by the previous challenge were resolved), participants crossed over into a different group, until they completed all 3 challenges (gluten, fructan, and placebo). Symptoms were measured by Gastrointestinal Symptom Rating Scale Irritable Bowel Syndrome (GSRS-IBS) version. A linear mixed model for analysis was used. RESULTS: Overall GSRS-IBS scores differed significantly during gluten, fructan, and placebo challenges; mean values were 33.1 ± 13.3, 38.6 ± 12.3, and 34.3 ± 13.9, respectively (P = .04). Mean scores for GSRS-IBS bloating were 9.3 ± 3.5, 11.6 ± 3.5, and 10.1 ± 3.7, respectively, during the gluten, fructan, and placebo challenges (P = .004). The overall GSRS-IBS score for participants consuming fructans was significantly higher than for participants consuming gluten (P = .049), as was the GSRS bloating score (P = .003). Thirteen participants had the highest overall GSRS-IBS score after consuming gluten, 24 had the highest score after consuming fructan, and 22 had the highest score after consuming placebo. There was no difference in GSRS-IBS scores between gluten and placebo groups. CONCLUSIONS: In a randomized, double-blind, placebo-controlled crossover study of individuals with self-reported non-celiac gluten sensitivity, we found fructans to induce symptoms, measured by the GSRS-IBS. Clinicaltrials.gov no: NCT02464150.
引用
- Skodje GI, Sarna VK, Minelle IH, et al. Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. Gastroenterology. 2017. PMID: 29102613. doi:10.1053/j.gastro.2017.10.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。